ESERIN BASE

Eserine (physostigmine) base is a reversible acetylcholinesterase inhibitor improving cholinergic function, used in glaucoma and anticholinergic toxicity. Side effects include sweating, bradycardia, and abdominal cramps. Only GMP materials will be supplied, logistics all according to GDP.

SKU: cf706fd73bcb Category: Tag:

Product Description


Mechanism of Action

Physostigmine is a reversible acetylcholinesterase (AChE) inhibitor. By preventing the breakdown of acetylcholine, it increases cholinergic neurotransmission at muscarinic and nicotinic receptors. It crosses the bloodbrain barrier and enhances central cholinergic tone.

Benefits and Advantages

Used in cholinesteraseinhibition studies, CNS cholinergicpathway modelling, antidotemechanism research, and neuromusculartransmission assays.

Side Effects and Risks

Risks include bradycardia, bronchospasm, excessive salivation, seizures (overdose) and cholinergic crisis. Handle with AChEinhibitor precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C23H29N3O2

Molecular Weight

235.33 g/mol

CAS Number

57-47-6

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

(3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl) N-methylcarbamate; (3,4,8B-Trimethyl-2,3A-Dihydro-1H-Pyrrolo(2,3-B)Indol-7-Yl) N-Methylcarbamate; RefChem:1050057; 1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate; CHEMBL11773

IUPAC/Chemical Name

3-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-4-yl)carbamate

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download